VE

Venus Concept IncNASDAQ VERO Stock Report

Last reporting period 30 Sep, 2024

Updated 24 Dec, 2024

Last price

Market cap $B

0.004

Micro

Exchange

XNAS - Nasdaq

VERO Stock Analysis

VE

Uncovered

Venus Concept Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-41/100

Low score

Market cap $B

0.004

Dividend yield

Shares outstanding

73.875 B

Venus Concept, Inc. develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related practice enhancement services. The company is headquartered in Toronto, Ontario and currently employs 407 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. Its products and services include main console and applicators/handpieces, marketing supplies and kits, consumables and disposables, replacement applicators/handpieces, and others. The company has developed and commercialized 11 technology platforms, including its ARTAS and NeoGraft systems. Its medical aesthetic technology platform is for a variety of indications, including treatment of facial wrinkles in certain skin types, temporary reduction of appearance of cellulite, non-invasive fat reduction (lipolysis) in the abdomen and flanks for certain body types and relief of minor muscle aches and pains in jurisdictions around the world. Venus Viva, Venus Viva MD, Venus Legacy, Venus Concept, Venus Versa, Venus Fiore, Venus Freedom, and others are trademarks of the Company.

View Section: Eyestock Rating